Edition:
United States

Momenta Pharmaceuticals Inc (MNTA.OQ)

MNTA.OQ on NASDAQ Stock Exchange Global Select Market

11.39USD
14 Dec 2018
Change (% chg)

$0.21 (+1.88%)
Prev Close
$11.18
Open
$11.14
Day's High
$11.50
Day's Low
$10.96
Volume
206,437
Avg. Vol
292,517
52-wk High
$32.15
52-wk Low
$10.10

Chart for

About

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. The Company has developed generic version of LOVENOX (enoxaparin sodium injection) and COPAXONE (glatiramer acetate injection). GLATOPA 20... (more)

Overall

Beta: 2.35
Market Cap(Mil.): $914.44
Shares Outstanding(Mil.): 78.56
Dividend: --
Yield (%): --

Financials

  MNTA.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -2.01 -- --
ROI: -44.33 0.60 13.80
ROE: -50.57 -2.18 15.29

Amphastar cannot collect $100 mln during Momenta drug patent appeal - judge

A federal judge on Monday ruled that Amphastar Pharmaceuticals Inc must wait to collect a $100 million bond that Momenta Pharmaceuticals Inc and Sandoz Inc posted in a drug patent case it won until after an appellate court hears the dispute.

Jul 16 2018

Earnings vs. Estimates